KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $456.4 million.

  • Staar Surgical's Liabilities and Shareholders Equity fell 1510.97% to $456.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 839.41%. This contributed to the annual value of $509.5 million for FY2024, which is 426.28% up from last year.
  • Latest data reveals that Staar Surgical reported Liabilities and Shareholders Equity of $456.4 million as of Q3 2025, which was down 1510.97% from $437.8 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Liabilities and Shareholders Equity registered a high of $537.6 million during Q3 2024, and its lowest value of $257.4 million during Q1 2021.
  • In the last 5 years, Staar Surgical's Liabilities and Shareholders Equity had a median value of $428.3 million in 2023 and averaged $412.6 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 3830.75% in 2021, then crashed by 1510.97% in 2025.
  • Staar Surgical's Liabilities and Shareholders Equity (Quarter) stood at $345.8 million in 2021, then rose by 21.12% to $418.8 million in 2022, then grew by 16.68% to $488.7 million in 2023, then grew by 4.26% to $509.5 million in 2024, then decreased by 10.43% to $456.4 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $456.4 million for Q3 2025, versus $437.8 million for Q2 2025 and $457.4 million for Q1 2025.